279.18
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché VEEV Giù?
Forum
Previsione
Precedente Chiudi:
$275.43
Aprire:
$276.77
Volume 24 ore:
909.54K
Relative Volume:
0.63
Capitalizzazione di mercato:
$45.62B
Reddito:
$2.86B
Utile/perdita netta:
$780.66M
Rapporto P/E:
59.15
EPS:
4.72
Flusso di cassa netto:
$1.20B
1 W Prestazione:
-1.23%
1M Prestazione:
+1.19%
6M Prestazione:
+19.23%
1 anno Prestazione:
+46.69%
Veeva Systems Inc Stock (VEEV) Company Profile
Nome
Veeva Systems Inc
Settore
Industria
Telefono
925-452-6500
Indirizzo
4280 HACIENDA DRIVE, PLEASANTON, CA
Confronta VEEV con altri titoli
Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
---|---|---|---|---|---|---|
![]()
VEEV
Veeva Systems Inc
|
279.18 | 45.26B | 2.86B | 780.66M | 1.20B | 4.72 |
![]()
TEM
Tempus Ai Inc
|
69.63 | 10.57B | 803.32M | -709.10M | -212.68M | -7.8003 |
![]()
DOCS
Doximity Inc
|
64.02 | 11.58B | 550.17M | 201.35M | 232.07M | 1.00 |
![]()
HQY
Healthequity Inc
|
89.27 | 8.00B | 1.15B | 96.70M | -161.99M | 1.09 |
![]()
WAY
Waystar Holding Corp
|
35.35 | 6.01B | 906.14M | -52.62M | 89.62M | -0.3621 |
Veeva Systems Inc Stock (VEEV) Upgrades & Downgrades
Data | Azione | Analista | Modifica della valutazione |
---|---|---|---|
2025-05-29 | Reiterato | Needham | Buy |
2025-01-23 | Downgrade | Goldman | Buy → Sell |
2024-12-20 | Iniziato | Stephens | Overweight |
2024-12-04 | Iniziato | Mizuho | Outperform |
2024-11-19 | Iniziato | Scotiabank | Sector Perform |
2024-10-08 | Iniziato | Exane BNP Paribas | Outperform |
2024-08-27 | Reiterato | Citigroup | Buy |
2024-07-09 | Iniziato | BTIG Research | Buy |
2023-10-25 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
2023-10-13 | Iniziato | Jefferies | Buy |
2023-06-28 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
2023-06-01 | Aggiornamento | Guggenheim | Neutral → Buy |
2023-03-17 | Downgrade | Truist | Buy → Hold |
2023-02-23 | Downgrade | Guggenheim | Buy → Neutral |
2023-01-04 | Aggiornamento | Barclays | Equal Weight → Overweight |
2022-12-06 | Iniziato | Cowen | Market Perform |
2022-12-02 | Reiterato | Needham | Buy |
2022-10-31 | Iniziato | Wells Fargo | Equal Weight |
2022-10-19 | Aggiornamento | JP Morgan | Underweight → Neutral |
2022-09-16 | Iniziato | KeyBanc Capital Markets | Overweight |
2022-07-27 | Iniziato | Oppenheimer | Outperform |
2022-06-23 | Iniziato | Goldman | Buy |
2022-06-21 | Ripresa | Guggenheim | Buy |
2022-03-03 | Downgrade | BofA Securities | Buy → Neutral |
2022-01-28 | Iniziato | Truist | Buy |
2022-01-07 | Downgrade | Stephens | Overweight → Equal-Weight |
2022-01-06 | Aggiornamento | SVB Leerink | Mkt Perform → Outperform |
2021-12-16 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
2021-10-01 | Ripresa | Stifel | Buy |
2021-09-02 | Reiterato | BofA Securities | Buy |
2021-09-02 | Reiterato | JMP Securities | Mkt Outperform |
2021-09-02 | Reiterato | Needham | Buy |
2021-09-02 | Reiterato | UBS | Neutral |
2021-07-21 | Iniziato | Cowen | Outperform |
2021-03-31 | Aggiornamento | UBS | Sell → Neutral |
2021-01-07 | Ripresa | KeyBanc Capital Markets | Overweight |
2020-12-09 | Downgrade | JP Morgan | Neutral → Underweight |
2020-10-14 | Ripresa | UBS | Sell |
2020-08-28 | Reiterato | Needham | Buy |
2020-07-23 | Iniziato | FBN Securities | Outperform |
2020-07-07 | Iniziato | Stephens | Overweight |
2020-06-08 | Iniziato | Citigroup | Buy |
2020-05-29 | Reiterato | Needham | Buy |
2020-04-13 | Iniziato | SVB Leerink | Mkt Perform |
2020-02-19 | Iniziato | Robert W. Baird | Outperform |
2020-02-14 | Iniziato | Piper Sandler | Overweight |
2020-01-13 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
2019-11-27 | Reiterato | Canaccord Genuity | Hold |
2019-09-26 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
2019-08-28 | Reiterato | Needham | Buy |
2019-06-07 | Iniziato | Goldman | Neutral |
2019-05-30 | Reiterato | BofA/Merrill | Buy |
2019-05-30 | Aggiornamento | Stephens | Equal-Weight → Overweight |
2019-05-24 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
2019-04-17 | Reiterato | Needham | Buy |
2019-02-27 | Reiterato | Needham | Buy |
Mostra tutto
Veeva Systems Inc Borsa (VEEV) Ultime notizie
Reasons to Add Veeva Systems Stock to Your Portfolio for Now - MSN
Veeva Systems Shares Dip 0.55% as Trading Volume Surges 60% to 310th Rank - AInvest
Research Shows Medtechs Prioritizing Site Collaboration and Data Quality - Veeva
Veeva Systems shares rise 1.16% premarket after announcing findings from the 2025 Veeva MedTech Clinical Benchmark. - AInvest
MedTech Clinical Trials Face Digital Gap: Only 14% of Large Companies Have Modern Site Tools - Stock Titan
eClinical Solutions Market Key Players AnalysisMedidata, Veeva Systems, Iqvia Inc., Icon Plc, Signant Health. - openPR.com
Veeva Systems Dips on 469th-Ranked Volume as Institutions Boost Holdings Amid Insider Share Sales - AInvest
2 Reasons to Watch VEEV and 1 to Stay Cautious - ca.finance.yahoo.com
Veeva Systems Inc. (VEEV) Is a Trending Stock: Facts to Know Before Betting on It - MSN
Is Veeva Systems Inc. in a consolidation phase3x Potential Swing Trade Ideas - thegnnews.com
Veeva Rises 0.85% as Trading Volume Falls to 413th Rank Amid Earnings Anticipation and Analyst Upgrade - AInvest
Veeva Stock Plummets 1.02% as Volume Surges 65% to Rank 325th in Activity - AInvest
Veeva Systems (VEEV) Declines More Than Market: Some Information for Investors - Yahoo Finance
Veeva Systems Inc. (VEEV): A Bull Case Theory - MSN
Veeva Q2 FY26 Earnings Call Scheduled: How to Access Financial Results August 27 - Stock Titan
Veeva Systems Tumbles 8.5% as Healthcare IT Sector Struggles with AI Hype Ranks 423rd in $290 Million Volume - AInvest
Veeva (VEEV) Upgraded to Buy: What Does It Mean for the Stock? - Yahoo Finance
Patient Data Hub Solutions Market Size, Share & Trends - GlobeNewswire
Patient Data Hub Solutions Market Size, Share & Trends Analysis Report 2025-2033, with Profiles of IQVIA, WellSky, Veeva Systems, Capgemini, Optum, ZS, Equipo Health, NXGN Management, and IntegriChain - Yahoo Finance
Veeva Systems and Sarah Cannon Partner to Accelerate Cancer Clinical Trials - MSN
Veeva Systems Gains 1.4% on AI Momentum Ranks 368th in 300M Dollar Daily Trading Volume - AInvest
Assessing Veeva Systems' Financial Health Through Return on Equity - AInvest
Is Veeva Systems Inc.'s (NYSE:VEEV) Latest Stock Performance A Reflection Of Its Financial Health? - Yahoo Finance
Breaking Silos in Cross-Functional KOL Engagement: Q&A with Astellas - Veeva
Does Veeva Systems Inc. stock perform well during market downturnsInvest confidently with professional market insights - Jammu Links News
Is Veeva Systems Inc. a good long term investmentFree Investment Community - Jammu Links News
Is Veeva Systems Inc. stock overvalued or undervaluedOutstanding investment returns - Jammu Links News
How volatile is Veeva Systems Inc. stock compared to the marketConsistently high yield - Jammu Links News
How strong is Veeva Systems Inc. company’s balance sheetBreakout stock performance - Jammu Links News
Is it the right time to buy Veeva Systems Inc. stockFree Predictions - Jammu Links News
What are Veeva Systems Inc. company’s key revenue driversHigh-octane gains - Jammu Links News
What are the latest earnings results for Veeva Systems Inc.Free Predictions - Jammu Links News
What is Veeva Systems Inc. company’s growth strategyFree Stock Market Return Analysis - Jammu Links News
Published on: 2025-08-03 15:07:21 - Jammu Links News
How does Veeva Systems Inc. generate profit in a changing economyFree Bull & Bear Market Updates - Jammu Links News
Is Veeva Systems Inc. a growth stock or a value stockMaximize your portfolio’s earning potential - Jammu Links News
What catalysts could drive Veeva Systems Inc. stock higher in 2025Achieve consistent double-digit returns - Jammu Links News
When is Veeva Systems Inc. stock expected to show significant growthNavigate market volatility with smart strategies - Jammu Links News
How many analysts rate Veeva Systems Inc. as a “Buy”Master the art of timing market moves - Jammu Links News
Veeva Systems Slides 1% on 280M-Dollar Volume as AI Rivals Challenge Healthcare Software Leadership - AInvest
Veeva Systems (VEEV) Stock Moves -1.09%: What You Should Know - Nasdaq
Veeva Systems Inc Class A to Host Earnings Call - ACCESS Newswire
Can Veeva's Vault R&D Keep Its Lead Amid Rising AI Competition? - Nasdaq
Veeva Systems Stock Is Up Nearly 40% This Year And Approaching A Buy Point - MSN
There's Reason For Concern Over Veeva Systems Inc.'s (NYSE:VEEV) Price - 富途牛牛
What are the technical indicators suggesting about Veeva Systems Inc.Financial News Planner For Consistent Profits - jammulinksnews.com
Veeva Systems Slides to 396th in Daily Trading Volume Despite AI-Driven Growth and Merck Partnership - AInvest
Why is Veeva Systems Inc. stock attracting strong analyst attentionPre Market Insights For Beginners - jammulinksnews.com
Veeva Systems Inc Azioni (VEEV) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):